Title
The cross-national epidemiology of DSM-IV intermittent explosive disorder
Date Issued
01 November 2016
Access level
open access
Resource Type
journal article
Author(s)
Scott K.M.
Lim C.C.W.
Hwang I.
Adamowski T.
Al-Hamzawi A.
Bromet E.
Bunting B.
Ferrand M.P.
Florescu S.
Gureje O.
Hinkov H.
Hu C.
Karam E.
Lee S.
Posada-Villa J.
Stein D.
Tachimori H.
Viana M.C.
Xavier M.
Kessler R.C.
Publisher(s)
Cambridge University Press
Abstract
Background This is the first cross-national study of intermittent explosive disorder (IED). Method A total of 17 face-to-face cross-sectional household surveys of adults were conducted in 16 countries (n = 88 063) as part of the World Mental Health Surveys initiative. The World Health Organization Composite International Diagnostic Interview (CIDI 3.0) assessed DSM-IV IED, using a conservative definition. Results Lifetime prevalence of IED ranged across countries from 0.1 to 2.7% with a weighted average of 0.8%; 0.4 and 0.3% met criteria for 12-month and 30-day prevalence, respectively. Sociodemographic correlates of lifetime risk of IED were being male, young, unemployed, divorced or separated, and having less education. The median age of onset of IED was 17 years with an interquartile range across countries of 13-23 years. The vast majority (81.7%) of those with lifetime IED met criteria for at least one other lifetime disorder; co-morbidity was highest with alcohol abuse and depression. Of those with 12-month IED, 39% reported severe impairment in at least one domain, most commonly social or relationship functioning. Prior traumatic experiences involving physical (non-combat) or sexual violence were associated with increased risk of IED onset. Conclusions Conservatively defined, IED is a low prevalence disorder but this belies the true societal costs of IED in terms of the effects of explosive anger attacks on families and relationships. IED is more common among males, the young, the socially disadvantaged and among those with prior exposure to violence, especially in childhood.
Start page
3161
End page
3172
Volume
46
Issue
15
Language
English
OCDE Knowledge area
Psiquiatría
Scopus EID
2-s2.0-84984706118
PubMed ID
Source
Psychological Medicine
ISSN of the container
00332917
Sponsor(s)
The WHO WMH Survey Initiative is supported by the National Institute of Mental Health (NIMH; R01 MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864 and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical, GlaxoSmithKline and Bristol-Myers Squibb.
Sources of information: Directorio de Producción Científica Scopus